Key result
In well-anticoagulated patients with atrial fibrillation, worsening renal function was independently associated with increased levels of endothelial/platelet microparticles (p < 0.001).
Why the study?
Is progressive renal dysfunction associated with increased levels of circulating microparticles and selectins in anticoagulated patients with atrial fibrillation?
Cross-Sectional (n=160)
No
Is progressive renal dysfunction associated with increased levels of circulating microparticles and selectins in anticoagulated patients with atrial fibrillation?
In anticoagulated patients with atrial fibrillation, worsening renal function is independently associated with elevated endothelial/platelet microparticles (EPMPs), suggesting a link between renal dysfunction and endothelial activation.
EPMP rise with worsening eGFR signals endothelial-renal interaction in anticoagulated AF; leaves open mechanistic and outcome implications.
Atrial fibrillation (AF) and chronic kidney disease are closely related, and any associated risk of stroke and thromboembolism due to AF is increased by concurrent renal dysfunction. The mechanism(s) for this include abnormalities in platelets and endothelial cells. We hypothesized relationships between levels of circulating platelet microparticles (PMPs, defined by CD42b), soluble P selectin (both reflecting platelet activation), soluble E-selectin (reflecting endothelial activation) and endothelial/platelet microparticles (EPMPs, defined by CD31) with progressive renal dysfunction. Blood samples were obtained from 160 anticoagulated AF patients. Microparticles were measured by flow cytometry, soluble E and P selectin levels by ELISA. Renal function was determined by estimated glomerular filtration rate (eGFR). EPMP levels demonstrated a linear increased trend across quartiles of eGFR (p = 0.034) and CKD stage (p < 0.001), and correlated with eGFR and serum creatinine (p < 0.01). PMPs, P-selectin and E-selectin levels were not significantly different across groupings of renal dysfunction, and no significant correlations with eGFR were evident (p = 0.186, p = 0.561, p = 0.746 respectively). Stepwise multivariable regression analysis demonstrated that worsening renal function was an independent predictor of EPMP levels (p < 0.001). In well-anticoagulated AF patients, there is potential relationship between endothelial function (as judged by elevated EPMP levels, with no change in PMPs) and renal function. Other markers of prothombotic state or cellular activation (PMP, P-selectin and E-selectin levels) were not significantly different across the various degree of renal dysfunction. Renal function must be addressed when measuring EPMP levels.
No takes yet. Share an insight, caveat, or question.
Lau et al. (2016) conducted a cross-sectional in Non-valvular atrial fibrillation (n=160). Worsening renal function (eGFR) vs. Normal or better renal function was evaluated on Endothelial/platelet microparticles (EPMPs) levels (r = -0.319, p=<0.001). In well-anticoagulated patients with atrial fibrillation, worsening renal function was independently associated with increased levels of endothelial/platelet microparticles (p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: